---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-22-067174"
form_type: "8-K"
ticker: "BJDX"
cik: "0001704287"
company_name: "Bluejay Diagnostics, Inc."
filed_at: "2022-10-28T23:59:59+00:00"
generated_at: "2026-06-22T22:45:14.469500+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Bluejay Diagnostics gets Nasdaq deficiency notice for bid price below $1.00

## Summary
- Received Nasdaq letter on Oct 25, 2022 for non-compliance with minimum bid price rule (NASDAQ 5550(a)(2)).
- Closing bid price below $1.00 for 30 consecutive business days; 180-day cure period ends April 24, 2023.
- To regain compliance, bid price must close at $1.00 or higher for at least 10 consecutive business days.
- If not cured, may be eligible for additional 180 days if meeting other listing standards; otherwise subject to delisting.
- Company intends to take all reasonable measures to regain compliance but no assurance of success.

## SEC filing metadata
- accession: 0001213900-22-067174
- form_type: 8-K
- ticker: BJDX
- cik: 0001704287
- company_name: Bluejay Diagnostics, Inc.
- filed_at: 2022-10-28T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1704287/000121390022067174/0001213900-22-067174-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1704287/000121390022067174/ea167648-8k_bluejay.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-22-067174
- JSON: https://secwatch.observer/filing/0001213900-22-067174.json
- Plain text: https://secwatch.observer/filing/0001213900-22-067174.txt

## Key facts
- Listing & Compliance Notices
  Bluejay Diagnostics, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2)
  source text: October 25, 2022, Bluejay Diagnostics, Inc. (the “Company”) received a notification letter from the Nasdaq Listing Qualifications Staff of The NASDAQ Stock Market LLC (“Nasdaq”) notifying the Company that the closing bid price for its common stock had been below $1.00 for the previous 30 consecutive business days and that the Company therefore is not in compliance with the minimum bid price requirement for continued inclusion on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2). The notification has no immediate effect on the listing of the Company’s common stock on The Nasdaq Cap
  evidence_url: https://www.sec.gov/Archives/edgar/data/1704287/000121390022067174/0001213900-22-067174-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.